Theravance Biopharma (TBPH) Cash from Investing Activities Growth (1y) (2014 - 2026)
Theravance Biopharma (TBPH) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Theravance Biopharma |
839.69 Mn |
445.03 Mn |
- |
71.69% |
| Date | Value |
|---|
| Mar 31, 2026 |
71.69% |
| Dec 31, 2025 |
-96.25% |
| Sep 30, 2025 |
-476.16% |
| Jun 30, 2025 |
-1,096.24% |
| Mar 31, 2025 |
79.89% |
| Dec 31, 2024 |
2,416.99% |
| Sep 30, 2024 |
-82,752.38% |
| Jun 30, 2024 |
-127.44% |
| Mar 31, 2024 |
139.56% |
| Dec 31, 2023 |
-100.06% |
| Sep 30, 2023 |
99.89% |
| Jun 30, 2023 |
47.00% |
| Mar 31, 2023 |
-234.84% |
| Dec 31, 2022 |
10,379.44% |
| Sep 30, 2022 |
44.89% |
| Jun 30, 2022 |
-78.99% |
| Mar 31, 2022 |
-71.92% |
| Dec 31, 2021 |
-79.33% |
| Sep 30, 2021 |
-153.79% |
| Jun 30, 2021 |
120.25% |
